Skip to main content
Medistim logo

Medistim — Investor Relations & Filings

Ticker · MEDI ISIN · NO0010159684 LEI · 5967007LIEEXZXJOX483 OL Manufacturing
Open in API
Filings indexed 783 across all filing types
Latest filing 2023-02-08 Major Shareholding Noti…
Country NO Norway
Listing OL MEDI

About Medistim

https://medistim.com/

Medistim is a medical technology company specializing in intraoperative quality assessment solutions. A pioneer and market leader in Transit Time Flow Measurement (TTFM), the company develops and manufactures advanced medical devices for use during surgical procedures. Its flagship MiraQ™ system uniquely combines TTFM with high-frequency ultrasound imaging, providing surgeons with real-time data to verify graft function and blood flow. This technology is applied in cardiac, vascular, and transplant surgery to enhance procedural quality control and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Major shareholder disclosure in Medistim ASA by Danske Bank AS
Major Shareholding Notification Classification · 99% confidence The document explicitly states it is a 'Major shareholder disclosure' concerning Danske Bank Group crossing the 5% ownership threshold in Medistim ASA. This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant share ownership levels crossing defined thresholds.
2023-02-08 English
Transfer of shares to CEO
Remuneration Information Classification · 99% confidence The document explicitly details the 'Transfer of shares to CEO' as part of her compensation agreement. This involves the movement of shares to an executive, which falls under insider transactions or director/executive dealings. The most specific category for personal share transactions by directors and executives is 'Director's Dealing' (DIRS). Although it mentions the Annual Report, the core subject is the share transfer to the CEO, not the Annual Report itself. It is not a general share repurchase (POS) as it is specific to executive compensation.
2023-01-25 English
Major shareholder disclosure in Medistim ASA by Danske Bank AS
Major Shareholding Notification Classification · 99% confidence The document explicitly states it is a "Major shareholder disclosure" concerning a change in holding that crosses a threshold (falling below 5%). This directly corresponds to the definition of a Major Shareholding Notification (MRQ), which covers changes in significant share ownership levels crossing thresholds.
2023-01-06 English
Financial calendar
Report Publication Announcement Classification · 99% confidence The document is titled 'Financial calendar' and lists scheduled dates for various corporate events throughout 2022 and 2023, including Quarterly Reports, Half-yearly Report, Annual Report, and Annual General Meeting (AGM). It is not the actual report or the AGM presentation itself, but rather a schedule of future corporate disclosures. Since there is no specific category for a 'Financial Calendar', and it is a general announcement regarding future corporate events/filings, the most appropriate fallback category is Regulatory Filings (RNS), as it is a general corporate disclosure required under continuing obligations.
2023-01-03 English
Medistim celebrate a long-standing relationship with the Japanese cardiac surgery community
Report Publication Announcement Classification · 99% confidence The document is a short press release dated December 2nd, 2022, celebrating Medistim's relationship with the Japanese cardiac surgery community and its market position at an International Coronary Congress. It contains company updates, quotes from executives and external parties, and contact information. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a detailed financial report (IR). It functions as a general corporate announcement or news item. Since it doesn't fit the specific categories like AGM-R, DIRS, DIV, or CAP, and it is an announcement rather than a detailed report, the most appropriate classification is the general regulatory/corporate announcement category, RNS, as it serves to disseminate general corporate news to the market.
2022-12-02 English
Third quarter results 2022 for Medistim ASA
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Medistim ASA's Interim report for the third quarter 2022'. It contains detailed financial statements (Profit and Loss, Balance Sheet), business segment updates, and performance analysis for the specified period. It is a comprehensive report rather than a short announcement or a transcript, fitting the definition of an Interim/Quarterly Report. Q3 2022
2022-10-28 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.